Ira Jacob Fox

Title: Ira Jacob Fox: Innovator in Genetic Engineering and Liver Disease Treatment

Introduction

Ira Jacob Fox is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the fields of genetic engineering and liver disease treatment. With a total of 2 patents, his work has the potential to impact medical science profoundly.

Latest Patents

One of Ira Jacob Fox's latest patents focuses on human induced pluripotent stem cells for high efficiency genetic engineering. The methods disclosed involve generating human induced pluripotent stem cells (iPSC) that contain a nucleic acid with a doxycycline promoter linked to a nucleic acid encoding Cas9. This innovative approach allows for high-efficiency CRISPR/Cas9-mediated recombination, enabling targeted gene editing. The iPSCs produced can be cultured in the presence of doxycycline to induce expression of Cas9, facilitating the introduction of nucleic acids encoding sgRNAs for gene targeting.

Another significant patent addresses methods for the treatment and prevention of liver disease. This invention reveals that hepatocyte nuclear factor 4 alpha (HNF4α), a transcription factor, can reverse hepatocyte dysfunction in an animal model of cirrhosis. This discovery leads to improvements in hepatic function, treatment of cirrhosis, and prolonged survival for affected individuals.

Career Highlights

Ira Jacob Fox is affiliated with the University of Pittsburgh, where he conducts his research and development work. His innovative approaches in the medical field have garnered attention and recognition.

Collaborations

Ira has collaborated with notable colleagues, including Alejandro Soto-Gutierrez and Alexandra Sylvie Collin De l'Hortet, who contribute to his research endeavors.

Conclusion

Ira Jacob Fox's contributions to genetic engineering and liver disease treatment exemplify the impact of innovative research in medicine. His patents reflect a commitment to advancing scientific knowledge and improving patient outcomes.